Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. - Toft-Nielsen,M.B.; Madsbad,S.; Holst,J.J. (Diabetes Care, 1999)